KRMD KORU Medical Systems, Inc. Accounting Capitalization

KORU Medical Systems (KRMD) develops portable devices for home drug administration, mitigating risks by operating in Europe and the US. This price chart confirms the asset's dynamics, where the indicator stands at 0.02. Revenue is generated through the sale of mechanical pumps and needles for immunoglobulins. The company's competitive advantage is driven by its niche leadership and the high switching costs for patients moving to alternative systems.

KORU Medical Systems is developing a high-tech subcutaneous infusion segment, leveraging patent protection and strict FDA certifications. Balance sheet capitalization is calculated as the difference between the company's total assets and all liabilities. This metric determines the actual value of net assets available to shareholders upon business liquidation. It is critical for investors to monitor this foundation to assess the issuer's solvency. This equity volume chart on GURU.Markets visualizes the risk of delisting in the event of a critical decline in asset value.